Kidney Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Nov 08, 2018
- Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
Zhou Liang et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Sep 1051155-1163 - Imaging findings of hereditary renal tumors, a review of what the radiologist should know.
Czarniecki Marcin et al. European journal of radiology 2018 Apr 1018-16 - Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.
Freifeld Yuval et al. Current urology reports 2018 Aug 19(10) 82 - Recommendations for the Management of Rare Kidney Cancers.
Giles Rachel H et al. European urology 2017 72(6) 974-983 - Renal cell cancer linked to Lynch syndrome: Increased incidence and loss of mismatch repair protein expression.
Therkildsen Christina et al. International journal of urology : official journal of the Japanese Urological Association 2016 23(6) 528-9 - Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.
Li Qing Kay et al. Seminars in cancer biology 2018 Jul - Broadening the View of Germline Mutations in Kidney Cancer.
Pilié Patrick G et al. JAMA oncology 2018 Jul - Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.
Büttner Florian et al. BMC medicine 2018 Jul 16(1) 108 - Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
MI Carlo et al, JAMA Oncology, July 5, 2018 - Applying Precision Oncology to Renal Cell Carcinoma: Emerging Challenges.
Leppert John T et al. European urology 2017 72(4) 565-566
No hay comentarios:
Publicar un comentario